ロード中...

A 4-miRNA signature predicts the therapeutic outcome of glioblastoma

Multimodal therapy of glioblastoma (GBM) reveals inter-individual variability in terms of treatment outcome. Here, we examined whether a miRNA signature can be defined for the a priori identification of patients with particularly poor prognosis. FFPE sections from 36 GBM patients along with overall...

詳細記述

保存先:
書誌詳細
出版年:Oncotarget
主要な著者: Niyazi, Maximilian, Pitea, Adriana, Mittelbronn, Michel, Steinbach, Joachim, Sticht, Carsten, Zehentmayr, Franz, Piehlmaier, Daniel, Zitzelsberger, Horst, Ganswindt, Ute, Rödel, Claus, Lauber, Kirsten, Belka, Claus, Unger, Kristian
フォーマット: Artigo
言語:Inglês
出版事項: Impact Journals LLC 2016
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5216759/
https://ncbi.nlm.nih.gov/pubmed/27302927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9945
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!